Short answer: Spain has no law that bans research peptides as substances. The Ley de garantías (Real Decreto Legislativo 1/2015) defines a medicine by presentation or by function, requires AEMPS authorisation before any medicine is marketed, and the AEMPS treats every unauthorised medicine as illegal. A vial sold and used as a laboratory reagent is outside that regime; a vial presented for human use is not, whatever the label says. Customs adds a second filter: only licensed laboratories and distributors may import medicines, so medicines posted from outside the EU to private individuals are stopped, while EU parcels face no customs step.
Disclosure: Peps and Protocols is published by the team behind Vitality Peps. Vendor facts below were checked on each vendor's public website on the date shown, and the criteria are the same for every vendor. This article is general information, not legal advice; rules change and enforcement varies, so check the current position with a qualified adviser in your country.
Buying a peptide sold as a laboratory reagent is not an offence in Spain and needs no licence. The line is drawn by article 2 of the Real Decreto Legislativo 1/2015, copied from Directive 2001/83/EC: a substance is a medicine if it is presented as having properties for treating disease, or if it can be administered to humans to modify physiological functions. Everything else depends on that line.
Once a product is a medicine, article 9 applies: no industrially made medicine may be placed on the market without prior AEMPS authorisation. The AEMPS's guide to how medicines are regulated states that "any medicine not authorised by the AEMPS is an illegal medicine" and that the AEMPS alone decides whether a product is a medicine. A supplier that makes no health claims and gives no instructions for use in people sells a chemical; a shop that presents the same vial for human use sells an illegal medicine, and the sticker does not change that.
BPC-157 has no marketing authorisation in Spain or in the EU; it does not appear in the AEMPS's CIMA register or among EMA-authorised medicines. It may be bought as a research reagent, but it cannot be sold, prescribed or dispensed as a medicine. For athletes, the WADA 2026 Prohibited List names BPC-157 under S0, non-approved substances.
The same holds for TB-500, GHK-Cu as an injectable, CJC-1295 and ipamorelin. For sellers the exposure is administrative before it is criminal: article 111.2 of the Ley de garantías classes marketing "products that are presented as medicines without being legally recognised as such" (c.14) and promoting unauthorised medicines (c.16) as very serious infringements, fined under article 114 from 90,001 to 1,000,000 euro. Health claims turn a lawful listing into an infringement.
Intended for human use, the vial is an unauthorised medicine, and Spanish customs treats it as one regardless of the label. The Agencia Tributaria's guide to internet purchases states that "the importation of medicines may only be carried out by laboratories and distribution entities" meeting the legal requirements, "so parcels containing medicines sent to private individuals are not permitted".
The same guide lists the outcomes when a private declaration turns out to contain medicines: return to origin, destruction, or a contraband file. Article 111.2.b.2 of the Ley de garantías makes importing medicines without authorisation a serious infringement, fined from 30,001 to 90,000 euro. Article 361 of the Código Penal punishes importing, supplying or marketing unauthorised medicines where this "creates a risk to life or health" with six months to three years' imprisonment; it exists for commercial distribution and marks the ceiling of the system, not the expected outcome of a personal order.
No. A pharmacy can only dispense authorised medicines, and it can only compound a fórmula magistral from substances whose action and indication are "legally recognised in Spain", as article 42.1 of the Ley de garantías requires. BPC-157, TB-500 and the other research peptides have no recognised action or indication in Spain, so a pharmacist has no legal basis to prepare them.
Article 42.6 routes compounding of substances not authorised in Spain through the special-situations regime of article 24, which requires AEMPS authorisation under Real Decreto 1015/2009 for identified patients; Real Decreto 175/2001 fixes the quality standards for any compounded preparation. Neither path is open to a person with a research vial. If no pharmacy may prepare it, the only lawful status left is the reagent.
From outside the EU, yes. Every non-EU parcel needs an import declaration, and the simplified declaration for private individuals cannot be used for goods under pharmaceutical control, which the Agencia Tributaria lists explicitly as "medicamentos"; a full DUA and the border pharmaceutical inspection apply. From another EU member state there is no declaration, no duty and no clearance step.
Three territories are special: Ceuta and Melilla are outside the EU customs territory and the Canary Islands outside the EU VAT area, so even shipments from the Península need a customs declaration, with IGIC in the Canaries, and many suppliers exclude them. Vitality Peps dispatches from Spain and the Netherlands within 24 hours with delivery in 1 to 3 business days, per its shipping policy; see also its guide to buying research peptides in Europe.
Sometimes, and the law gives you the test. A supplier that lists a reagent, publishes a batch-specific certificate of analysis from a named laboratory, makes no health claims and gives no instructions for use in people is selling what it says. A shop that adds human-use guides or health promises is presenting a medicine, and under article 2 of the Ley de garantías presentation is enough.
Four checks: the certificate must carry your vial's batch number, as the guide to reading a peptide COA explains; the warehouse must be inside the EU; payment should run through a licensed provider; and the product page should describe published research, not results for you. Vitality Peps publishes Janoshik Analytical reports per batch on its lab results page.
Expect card and SEPA bank transfer; Bizum is rarely offered by research suppliers. One Spanish-language vendor FAQ checked on 3 September 2026 lists only card or bank transfer, and Vitality Peps lists card, Apple Pay, Google Pay and crypto on its how-to-order page. Card payment preserves chargeback rights; crypto-only checkouts do not.
Delivery from EU stock to a Spanish address takes 1 to 3 business days in the cases we checked, against five to ten days plus clearance from outside the EU. Unmarked packaging is standard and changes nothing legally: what matters is the presentation on the seller's site, not the box.
| Scenario | What the law says | Source |
|---|---|---|
| Reagent from an EU supplier, no health claims, no instructions for human use | Not a medicine by presentation; free movement, no customs step | RDL 1/2015 art. 2; Directive 2001/83/EC art. 1(2) |
| Vial presented for human use, posted from outside the EU | Unauthorised medicine; private import not permitted; return, destruction or contraband file | Agencia Tributaria, Compras por Internet; RDL 1/2015 art. 111.2.b.2 |
| Web shop offering peptides for human use | Very serious infringement, up to 1,000,000 euro; art. 361 CP if a health risk arises | RDL 1/2015 art. 111.2.c.14, 114; CP art. 361 |
| Asking a pharmacy to compound it | Not possible: no legally recognised action or indication | RDL 1/2015 art. 42.1, 42.6 |
| Shipping to the Canaries, Ceuta or Melilla | Customs declaration even from the Península; many suppliers exclude them | Agencia Tributaria, envíos para particulares |
As a laboratory reagent from an EU supplier, yes: it is not a controlled substance in Spain and moves freely inside the EU. As a medicine it is unauthorised everywhere in the EU, so presenting it for human use is illegal for the seller. Germany also lists thymosin beta-4 derivatives in its anti-doping law.
Both may be bought as research reagents and neither is a controlled substance in Spain. Neither has a marketing authorisation, so neither can be sold for human use or compounded by a pharmacy. Both are listed by WADA under S2, so licensed athletes face sporting sanctions whatever the purchase's legal status.
The question mixes two regimes. Buying a reagent is lawful; selling a product presented for muscle growth makes it a medicine by presentation, which is unlawful without authorisation. For competing athletes WADA prohibits BPC-157 (S0) and the growth hormone secretagogues (S2) at all times, whatever the label says.
The Agencia Tributaria lets travellers carry medicines for their own use without prior health inspection, but the traveller must be able to prove that use, for example with a prescription. No prescription can exist for an unauthorised product, so a vial presented as a medicine has no traveller exemption.
A research supplier should, and it should be batch-specific and come from a named independent laboratory rather than the manufacturer. Match the batch number on the report to the vial and check the method (HPLC for purity, mass spectrometry for identity). Vitality Peps publishes Janoshik Analytical reports per batch.